Mats Wahlgren

Title: The Innovations of Mats Wahlgren

Introduction

Mats Wahlgren is a notable inventor based in Stocksund, Sweden. He has made significant contributions to the field of medical science, particularly in the development of chemically modified heparins. With a total of 3 patents, his work has the potential to impact treatments for various diseases.

Latest Patents

Wahlgren's latest patents include a groundbreaking invention related to low anticoagulant heparins. This invention pertains to a chemically modified heparin that exhibits an antifactor II activity of less than 10 IU/mg and an antifactor Xa activity of less than 10 IU/mg, with an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Additionally, he has developed a method for preparing this heparin and its medical applications, including the treatment of malaria. Another significant patent involves the use of chemically modified heparin derivatives in the treatment of sickle cell disease, which also features similar activity levels and molecular weight specifications.

Career Highlights

Throughout his career, Mats Wahlgren has worked with various companies, including Dilaforette AB and Karolinska Innovations AB. His expertise in the field has allowed him to contribute to innovative solutions in medical treatments.

Collaborations

Wahlgren has collaborated with notable individuals such as Hans-Peter Ekre and Anna Leitgeb, further enhancing the impact of his inventions.

Conclusion

Mats Wahlgren's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatment methodologies.